Evidence map›Paper›PMID 34143203›Full record

ArticleDevelopment (Cambridge, England)2021

A transgenic system for targeted ablation of reproductive and maternal-effect genes.

Sylvain Bertho, Odelya Kaufman, KathyAnn Lee, Adrian Santos-Ledo, Daniel Dellal, Florence L Marlow

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sylvain BerthoDepartment of Cell, Developmental and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1020 New York, NY 10029-6574, USA.
Odelya KaufmanDepartment of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx NY 10461, USA.
KathyAnn LeeDepartment of Cell, Developmental and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1020 New York, NY 10029-6574, USA.
Adrian Santos-LedoDepartment of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx NY 10461, USA.
Daniel DellalDepartment of Cell, Developmental and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1020 New York, NY 10029-6574, USA.
Florence L MarlowDepartment of Cell, Developmental and Regenerative Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place Box 1020 New York, NY 10029-6574, USA.ORCID 0000-0002-9362-0342
Albert Einstein College of Medicine · USIcahn School of Medicine at Mount Sinai · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
A Transgenic System for Targeted Ablation of Reproductive and Maternal-EffectgenesR21HD091456 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARLOW, FLORENCE LOUISE · 2018 to 2019
$466k
The Role of Rbpms2 in establishing oocyte polarityF30HD082903 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KAUFMAN, ODELYA HARTUNG · 2015 to 2016
$97k
NICHD NIH HHS F30 HD082903NICHD NIH HHS R21 HD091456NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Maternally provided gene products regulate the earliest events of embryonic life, including formation of the oocyte that will develop into an egg, and eventually into an embryo. Forward genetic screens have provided invaluable insights into the molecular regulation of embryonic development, including the essential contributions of some genes whose products must be provided to the transcriptionally silent early embryo for normal embryogenesis, called maternal-effect genes. However, other maternal-effect genes are not accessible due to their essential zygotic functions during embryonic development. Identifying these regulators is essential to fill the large gaps in our understanding of the mechanisms and molecular pathways contributing to fertility and to maternally regulated developmental processes. To identify these maternal factors, it is necessary to bypass the earlier requirement for these genes so that their potential later functions can be investigated. Here, we report reverse genetic systems to identify genes with essential roles in zebrafish reproductive and maternal-effect processes. As proof of principle and to assess the efficiency and robustness of mutagenesis, we used these transgenic systems to disrupt two genes with known maternal-effect functions: kif5ba and bucky ball.

Indexed as

Gene Knockdown TechniquesGene TargetingMaternal InheritanceTransgenesAnimalsAnimals, Genetically ModifiedEmbryonic DevelopmentGene ExpressionGenetic VectorsGerm CellsHumansMutagenesisReproducibility of ResultsReproductionGerm cellsMaternal effectMutagenesis

Identifiers

PMID34143203
PMCPMC8254866
OpenAlexW3168371421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.